A phase 1 dose escalation study of imatinib mesylate plus standard-dosed temozolomide in the treatment of patients with malignant glioma

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sathornsumetee, S; Reardon, DA; Quinn, J; Rich, JN; Vredenburgh, JJ; Desjardins, A; Gururangan, S; Lyons, P; Salvado, A; Friedman, HS

Published Date

  • June 1, 2005

Published In

Volume / Issue

  • 23 / 16

Start / End Page

  • 124S - 124S

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 13, 2005

Conference End Date

  • May 17, 2005